Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Sep;23(5):1375-1391.
doi: 10.1007/s10238-022-00885-2. Epub 2022 Sep 13.

The role and function of CLU in cancer biology and therapy

Yefei Zhang #  1 , Xiang Lv #  1 , Liming Chen  2 , Yan Liu  3
Affiliations
Review

The role and function of CLU in cancer biology and therapy

Yefei Zhang et al. Clin Exp Med. 2023 Sep.

Abstract

Clusterin (CLU) is a highly evolutionary conserved glycoprotein with multiple isoform-specific functions and is widely distributed in different species. Accumulated evidence has shown the prominent role of CLU in regulating several essential physiological processes, including programmed cell death, metastasis, invasion, proliferation and cell growth via regulating diverse signaling pathways to mediate cancer progression in various cancers, such as prostate, breast, lung, liver, colon, bladder and pancreatic cancer. Several studies have revealed the potential benefit of inhibiting CLU in CLU inhibition-based targeted cancer therapies in vitro, in vivo or in human, suggesting CLU is a promising therapeutic target. This review discusses the multiple functions and mechanisms of CLU in regulating tumor progression of various cancers and summarizes the inhibitors of CLU used in CLU inhibition-based targeted cancer therapies.

Keywords: Cancer progression; Cancer therapy; Clusterin (CLU).

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Jones TE, Jomary C. Clusterin. Int J Biochem Cell Biol. 2002;34:427–31. - PubMed - DOI
    1. Praharaj PP, et al. Clusterin as modulator of carcinogenesis: a potential avenue for targeted cancer therapy. Biochim Biophys Acta Rev Cancer. 2021;1875(2):188500. - PubMed - DOI
    1. Wu Q, et al. In vivo CRISPR screening unveils histone demethylase UTX as an important epigenetic regulator in lung tumorigenesis. Proc Natl Acad Sci U S A. 2018;115(17):E3978–86. - PubMed - PMC - DOI
    1. Bettuzzi S, et al. Genetic inactivation of ApoJ/clusterin: effects on prostate tumourigenesis and metastatic spread. Oncogene. 2009;28(49):4344–52. - PubMed - DOI
    1. Rizzi F, Coletta M, Bettuzzi S Chapter 2: Clusterin (CLU): From one gene and two transcripts to many proteins. Advances in cancer research, 2009. 104(1): p. 9–23.

LinkOut - more resources